Article

Patent issued for Iridex probes

The U.S. Patent and Trademark Office has issued a patent to Iridex Corp. that applies to a group of laser handpieces used in invasive ophthalmic surgical procedures, according to the company.

Mountain View, CA-The U.S. Patent and Trademark Office has issued a patent to Iridex Corp. that applies to a group of laser handpieces used in invasive ophthalmic surgical procedures, according to the company.

The patent, numbered 7,909,816 and titled “Directional Probe Treatment Apparatus,” applies to a number of consumable medical devices already in the company’s product line and known by a collective name (Stepped Angled EndoProbe laser handpieces).

“This is an important patent for us because our . . . probes are the best-selling product line within our consumable product portfolio,” said Theodore A. Boutacoff, Iridex president and chief executive officer. “This patent helps us further differentiate our products from our competitors and creates new barriers for competition.”

Boutacoff said the company intends to expand its product line with additional versions of the handpieces. Currently, the devices are available in 20, 23, and 25 gauges.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.